Prosocial effects of MDMA: A measure of generosity

Journal of Psychopharmacology
Matthew G KirkpatrickHarriet de Wit

Abstract

3,4-methylenedioxymethamphetamine (MDMA) produces "prosocial" effects that contribute to its recreational use. Few studies have examined the cognitive and behavioral mechanisms by which MDMA produces these effects. Here we examined the effect of MDMA on a specific prosocial effect, i.e. generosity, using a task in which participants make decisions about whether they or another person will receive money (Welfare Trade-Off Task; WTT). The project included one study without drug administration and one with MDMA. In Study 1, we administered the WTT to healthy adults (N = 361) and examined their performance in relation to measures of personality and socioeconomic status. In Study 2, healthy volunteers with MDMA experience (N = 32) completed the WTT after MDMA administration (0, 0.5, or 1.0 mg/kg). As expected, in both studies participants were more generous with a close friend than an acquaintance or stranger. In Study 1, WTT generosity was related to household income and trait Agreeableness. In Study 2, MDMA (1.0 mg/kg) increased generosity toward a friend but not a stranger, whereas MDMA (0.5 mg/kg) slightly increased generosity toward a stranger, especially among female participants. These data indicate that the WTT is a valuable...Continue Reading

References

Nov 5, 1997·Journal of Personality and Social Psychology·P A Van LangeJ A Joireman
Apr 21, 2001·Psychopharmacology·M E LiechtiF X Vollenweider
Nov 21, 2001·Drug and Alcohol Dependence·M E Tancer, C E Johanson
Aug 13, 2002·Psychopharmacology·Debra S HarrisReese T Jones
Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·Tara L WhiteHarriet de Wit
Jan 13, 2006·Journal of Psychopharmacology·Harry R SumnallLisa Jerome
Apr 21, 2006·Psychological Science·Bryan Jones, Howard Rachlin
Nov 8, 2007·PloS One·Paul J ZakSheila Ahmadi
Jul 16, 2008·Behavioural Processes·Howard Rachlin, Bryan A Jones
Feb 24, 2009·Journal of the Experimental Analysis of Behavior·Bryan A Jones, Howard Rachlin
Aug 15, 2009·Psychopharmacology·Gillinder BediHarriet de Wit
Jul 24, 2010·Journal of Personality and Social Psychology·Paul K PiffDacher Keltner
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Molly J CrockettTrevor W Robbins
May 21, 2011·Hormones and Behavior·Jorge A BarrazaPaul J Zak
Jan 27, 2012·Psychopharmacology·Cédric M HysekMatthias E Liechti
Oct 27, 2012·Hormones and Behavior·Birgit DerntlUte Habel
Nov 20, 2012·Evolution and Human Behavior : Official Journal of the Human Behavior and Evolution Society·Andrew W Delton, Theresa E Robertson
Aug 22, 2013·Personality & Social Psychology Bulletin·Paul K Piff
Oct 8, 2013·Social Cognitive and Affective Neuroscience·Cédric M HysekMatthias E Liechti
Jan 23, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthew G KirkpatrickHarriet de Wit
Apr 15, 2014·Psychopharmacology·Margaret C Wardle, Harriet de Wit
Jun 3, 2014·Psychoneuroendocrinology·Matthew G KirkpatrickSuma Jacob

❮ Previous
Next ❯

Citations

Sep 27, 2015·Neuroscience and Biobehavioral Reviews·Philip Kamilar-Britt, Gillinder Bedi
Feb 7, 2016·Psychological Science·Max M KrasnowJohn Tooby
Aug 27, 2016·Journal of Psychopharmacology·Anya K BershadHarriet de Wit
May 20, 2017·The International Journal of Neuropsychopharmacology·André SchmidtStefan Borgwardt
Feb 23, 2018·Psychopharmacology·Harriet de Wit, Michael Sayette
Dec 6, 2017·The International Journal of Neuropsychopharmacology·André SchmidtStefan Borgwardt
Feb 6, 2019·Journal of Psychopharmacology·Molly CarlyleCelia Ja Morgan
Nov 17, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Friederike HolzeMatthias E Liechti
Jun 2, 2020·Expert Review of Clinical Pharmacology·Kyle T GreenwayAllison A Feduccia
Jan 6, 2018·Expert Opinion on Drug Metabolism & Toxicology·E PapaseitM Farré
Dec 19, 2019·Frontiers in Psychiatry·Katrin H Preller, Franz X Vollenweider
Apr 23, 2017·Psychopharmacology·Anya K BershadHarriet de Wit
Sep 19, 2020·Psychological Science·Joshua M TyburReinout E de Vries
May 5, 2021·Journal of Psychopharmacology·Harriet de WitCharles Grob
Aug 20, 2021·Frontiers in Psychiatry·Nicolas LanglitzDimitris Repantis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Neuropsychiatry and Clinical Neurosciences
Francis L StevensKatherine H Taber
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Matthew G KirkpatrickHarriet de Wit
© 2022 Meta ULC. All rights reserved